DICOM PS3.20 2024c - Imaging Reports using HL7 Clinical Document Architecture |
---|
Contains information related to the radiation exposure and protection of the patient, as may be required by national or local legal requirements or standards. |
|
Included in 9.3 Imaging Procedure Description |
|
(73569-6, LOINC, "Radiation exposure and protection information") |
||||||||
9.1.1 Section Text 1.2.840.10008.9.19 |
||||||||
10.8 SOP Instance Observation 1.2.840.10008.9.18 |
||||||||
10.1 Coded Observation 2.16.840.1.113883.10.20.6.2.13 |
||||||||
10.1 Coded Observation 2.16.840.1.113883.10.20.6.2.13 |
||||||||
10.5 Quantity Measurement 2.16.840.1.113883.10.20.6.2.14 |
||||||||
(440252007, SNOMED, "Administration of radiopharmaceutical") |
||||||||
ValueSet CID 25 “Radiopharmaceutical”, or CID 4021 “PET Radiopharmaceutical” |
||||||||
The section text SHALL contain information related to the radiation exposure and protection of the patient, as is required by state/national legal requirements or standards, for example:
the name of the "Irradiation Authorizing" person who is the clinician responsible for determining that the irradiating procedure was appropriate for the indications.
summary information on radiation exposure if ionizing is applied in the context of the current procedure (detailed specification of exposure is out of the scope of this textual summary).
information on the radioactive substance administered if radioactive substance is administered in the context of the current procedure.
Compare to TID 2008 “Radiation Exposure and Protection Information”.
DICOM PS3.20 2024c - Imaging Reports using HL7 Clinical Document Architecture |
---|